Role of α2-agonists in the treatment of acute alcohol withdrawal;El papel de los agonistas α2 en el tratamiento de la abstinencia aguda de alcohol

Annals of Pharmacotherapy

Volumn 45, Issue 5, 2011, Pages 649-657

  Muzyk, Andrew J ^a   Fowler, Jill A ^b   Norwood, Daryn K ^c   Chilipko, Allison ^d  

^a Campbell University   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c Internal Medicine   (United States)

^d UNION MEMORIAL HOSPITAL   (United States)

Author keywords

2 Agonist; Alcohol withdrawal; Clonidine; Delirium tremens; Dexmedetomidine; Norepinephrine; Sympathetic overdrive

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CHLORPROTHIXENE; CLOMETHIAZOLE; CLONIDINE; DEXMEDETOMIDINE; DIAZEPAM; DIPHENHYDRAMINE; DIXYRAZINE; FLUNITRAZEPAM; HALOPERIDOL; LORAZEPAM; METHAQUALONE; MIDAZOLAM; NORADRENALIN; OXAZEPAM; PHENYTOIN; PLACEBO; PROPRANOLOL; THIAMINE;

AGITATION; ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ANXIETY; ARTICLE; BRADYCARDIA; CONTINUOUS INFUSION; DELIRIUM; DIZZINESS; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HALLUCINATION; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; LOADING DRUG DOSE; LOW DRUG DOSE; META ANALYSIS; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPEATED DRUG DOSE; SEIZURE; TACHYCARDIA; TREMOR;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; CLONIDINE; DEXMEDETOMIDINE; ETHANOL; HUMANS; NOREPINEPHRINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 79957618185     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P575     Document Type: Article

References (50)

1. McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry 2008;79:854-62. DOI 10.1136/jnnp.2007.128322
2. DeBellis R, Smith BS, Choi S, Malloy M. Management of delirium tremens. J Intensive Care Med 2005;20:164-73. DOI 10.1177/0885066605275353
3. Bayard M, McIntyre J, Hill KR, Woodside J. Alcohol withdrawal syndrome. Am Fam Physician 2004;69:1443-50.
4. Mayo-Smith MF, Beecher LH, Fisher TL, et al. Management of alcohol withdrawal delirium: an evidence-based practice guideline. Arch Intern Med 2004;164:1405-12.
5. Kleber HD, Weiss RD, Anton RF Jr, et al. Treatment of patients with substance use disorders, 2nd ed. American Psychiatric Association. Am J Psychiatry 2006;163(8 suppl):5-82.
6. Ntais C, Pakos E, Kyzas P, Ioannidis JP. Benzodiazepines for alcohol withdrawal. Cochrane Database System Reviews 2005, Issue 3. Art. No. CD005063. DOI 10.1002/14651858.CD005063.pub2
7. Gish EC, Miller JL, Honey BL, Johnson PN. Lofexidine, an a2-receptor agonist for opioid detoxification. Ann Pharmacother 2010;44:343-51. DOI 10.1345/aph.1M347
8. Lê AD, Harding S, Juzytsch W, Funk D, Shaham Y. Role of alpha-2 adrenocepters in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology 2005;179:366-73. DOI 10.1007/s00213-004-2036-y
9. Hemmingsen R, Clemmesen L, Barry DI. Blind study of the effect of the alpha-adrenergic agonists clonidine and lofexidine on alcohol withdrawal in the rat. J Stud Alcohol 1984;45:310-5.
10. Cushman P, Forbes R, Lerner W, Stewart M. Alcohol withdrawal syndromes: clinical management with lofexidine. Alcohol Clin Exp Res 1985;9:103-8.
11. Cushman P, Sowers JR. Alcohol withdrawal syndrome: clinical and hormonalresponses to a2-adrenergic agonist treatment. Alcohol Clin Exp Res 1989;13:361- 4.
12. Brunning J, Mumford JP, Keaney FP. Lofexidine in alcohol withdrawal states. Alcohol Alcohol 1986;21:167-70.
13. Keaney F, Strang J, Gossop M, et al. A double-blind randomized placebo- controlled trial of lofexidine in alcohol withdrawal: lofexidine is not a useful adjunct to chlordiazepoxide. Alcohol Alcohol 2001;36:426-30. DOI 10.1093/alcalc/36.5.426
14. Bjorkqvist SE. Clonidine in alcohol withdrawal. Acta Psychiatr Scand 1975;52:256-63.
15. Walinder J, Balldin J, Bokstrom K, Karlsson I, Lundstrom B. Clonidine suppression of the alcohol withdrawal syndrome. Drug Alcohol Depend 1981;8:345-8.
16. Manhem P, Nilsson LH, Moberg AL, et al. Alcohol withdrawal: effects of clonidine treatment on sympathetic activity, the renin-aldosterone system, and clinical symptoms. Alcohol Clin Exp Res 1985;9:238- 43.
17. Wilby MJ, Hutchinson PJ. The pharmacology of chlormethiazole: a potential neuroprotective agent? CNS Drug Rev 2004;10:281-94.
18. Baumgartner GR, Rowen RC. Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med 1987; 147:1223-6.
19. Baumgartner GR, Rowen RC. Transdermal clonidine versus chlordiazepoxide in alcohol withdrawal: a randomized, controlled clinical trial. South Med J 1991;84:312-21.
20. Robinson BJ, Robinson GM, Maling TJB, Johnson RH. Is clonidine useful in the treatment of alcohol withdrawal? Alcohol Clin Exp Res 1989; 13:95-8.
21. Adinoff B. Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings. Alcohol Clin Exp Res 1994;18:873-8.
22. Ip Yam PC, Forbes A, Kox WJ. Clonidine in the treatment of alcohol withdrawal in the intensive care unit. Br J Anaesth 1992;69:328.
23. Spies CD, Dubisz N, Neumann T, et al. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med 1996;24:414-22.
24. Stieger DS, Cantieni R, Frutiger A. Acute colonic pseudoobstruction (Ogilvie's syndrome) in two patients receiving high dose clonidine for delirium tremens. Intensive Care Med 1997;23:780-2.
25. Maccioli GA. Dexmedetomidine to facilitate drug withdrawal. Anesthesiology 2003;98:575-7.
26. Rovasalo A, Tohmo H, Aantaa R, Kettunen E, Palojoki R. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report. Gen Hosp Psychiatry 2006;28:362-3. DOI 10.1016/j.genhosppsych.2006.03.002
27. Darrouj J, Puri N, Prince E, Lomonaco A, Spevetz A, Gerber DR. Dexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawal. Ann Pharmacother 2008;42:1703-5. DOI 10.1345/aph.1K678
28. Bamgbade OA. Dexmedetomidine for peri-operative sedation and analgesia in alcohol addiction. Anaesthesia 2006;61:295-306. DOI 10.1111/j.1365-2044.2006.04559.x
29. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. JAMA 1997;278: 144-51.
30. Myrick H, Anton RF. Treatment of alcohol withdrawal. Alcohol Health Res World 1998;22:38- 43.
31. Borg S, Kvande H, Sedvall G. Central norepinephrine metabolism during alcohol intoxication in addicts and health volunteers. Science 1981;213: 1135-7.
32. Hawley RJ, Nemeroff CB, Bissette G, et al. Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcohol Clin Exp Res 1994;18:1312-6.
33. Linnoila M, Mefford I, Nutt D, Adinoff B. NIH Conference. Alcohol withdrawal and noradrenergic function. Ann Intern Med 1987;107:875-89.
34. Krystal JH, Webb E, Cooney NL, Kranzler HR. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenypiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. Am J Psychiatry 1996:153:83-92.
35. Walker BM, Rasmussen DD, Raskind MA, Koob GF. Alpha-1 noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 2008;42:91-7. DOI 10.1016/j.alcohol.2007.12.002
36. Brewer C. Second-line and 'alternative' treatments for alcohol withdrawal: alpha-agonists, beta-blockers, anticonvulsants, acupuncture and neuro- electric therapy. Alcohol & Alcohol 1995;30:799-803.
37. Krystal JH, Tabakoff B. Ethanol abuse, dependence, and withdrawal: neurobiology and clinical implications. In: Davis KL, Charney D, Coyle JT, Nemeroff C. Neuropsychopharmacology: 5th Generation of Progress. New York, NY: Lippincott Williams and Wilkins, 2002:1425-43.
38. Patkar AA, Gopalakrishnan R, Naik PC, Murray HW, et al. Changes in plasma noradrenaline and serotonin levels and craving during alcohol withdrawal. Alcohol Alcohol 2003:38:224-31. DOI 10.1093/alcalc/agg055
39. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644-53.
40. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009;301:489-99. DOI 10.1001/jama.2009.56
41. Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie W, Bellomo R. Dexmedetomidine vs haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care 2009;13:R75. DOI 10.1186/cc7890
42. O'Brien JM, Lu B, Ali NA, et al. Alcohol dependence is independently associated with sepsis, septic shock, and hospital mortality among adult intensive care unit patients. Crit Care Med 2007;35:345-50. DOI 10.1097/01.CCM.0000254340.91644.B2
43. Haselman MA. Dexmedetomidine: a useful adjunct to consider in some high-risk situations. AANA J 2008;76:335-9.
44. Jaatinen P, Riihioja P, Haapalinna A, Heinonen E, Kiianmaa K, Hervonen A. Prevention of ethanol-induced sympathetic overactivity and degeneration by dexmedetomidine. Alcohol 1995;12:439- 46. DOI 10.1016/0741-8329(95)00027-O
45. Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A. Dexmedetomidine, diazepam, and propranolol in the treatment of ethanol withdrawal symptoms in the rat. Alcohol Clin Exp Res 1997;21: 804-8. DOI 10.1111/j.1530-0277.1997.tb03843.x
46. Riihioja P, Jaatinen P, Oksanen H, Haapalinna A, Heinonen E, Hervonen A. Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat. Alcohol 1997;14:537-44. DOI 10.1016/S0741-8329(97)00044-X
47. Gerlach AT, Dasta JF. Dexmedetomidine: an updated review. Ann Pharmacother 2007;41:245-52. DOI 10.1345/aph.1H314
48. Gerlach AT, Murphy CV, Dasta JF. An updated focused review of dexmedetomidine in adults. Ann Pharmacother 2009;43:2064-74. DOI 10.1345/aph.1M310
49. Szumita PM, Baroletti SA, Anger KE, Wechsler ME. Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine. Am J Health Syst Pharm 2007;64:37-44. DOI 10.2146/ajhp050508
50. Boyer J. Treating agitation with dexmedetomidine in the ICU. Dimens Crit Care Nurs 2009;28:102- 9. DOI 10.1097/DCC.0b013e31819aef3d